Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06638645

Prolonged Hospital Stay After Thoracoscopic Anatomical Lung Resections

In this study, the reasons for prolonged hospital stay after thoracoscopic (video- or robot-assisted) anatomical lung resections are investigated. Currently, whenever possible, these anatomical lung resections are performed thoracoscopically, as they offer significant improvements in terms of postoperative pain, number of postoperative complications, rehabilitation, tolerance for adjuvant chemotherapy, and length of hospital stay. The development of an 'Enhanced Recovery After Surgery' (ERAS) protocol for lung surgery has further reduced hospital stay and the need for opioids for analgesia. Despite the optimal implementation of the ERAS protocol, there are still patients who need to stay in the hospital longer than the median. The aim of this research is to investigate the reasons for this.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

AZ Sint-Jan Brugge-Oostende AV, Bruges, Belgium

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients referred for elective minimally invasive (uniportal or multiportal video- or robot-assisted) anatomical lung resection (lobectomy or segmentectomy)
  • Informed consent obtained pre-operatively
  • Age 18 years or older

Exclusion criteria

  • Patients younger than 18 years old
  • Traumatic event as indication for lung resection
  • Non-anatomical lung resections
  • Thoracotomy
  • Patients already hospitalized for other pathologies, pre-existent and not related to the lung surgery
  • Urgent/emergency procedures

Treatment and study plan

VATS/RATS anatomical lung resection

Procedure

Perioperative care according to the ERAS protocol for lung surgery

Other names: VATS lobectomy, RATS lobectomy, VATS segmentectomy, RATS segmentectomy

Primary outcomes

  1. Length of hospital stay (days)

    Time frame: immediately after surgery until hospital discharge (1 week on average), up to 3 months

    The primary objective is to investigate the length of hospital stay of patients undergoing minimally invasive thoracoscopic anatomical lung resection with peri-operative care according to the Enhanced Recovery After Surgery (ERAS) protocol for lung surgery

Secondary outcomes

  1. Reasons for delayed discharge (more than 2 days postoperatively) identified through daily questionnaires and review of medical records.

    Time frame: immediately after surgery until hospital discharge (1 week on average), up to 3 months

    • Postoperative pain (NRS)
    • Postoperative nausea and vomiting (yes/no)
    • Air leak duration (days)
  2. Number, frequency and severity of postoperative complications during hospital stay.

    Time frame: immediately after surgery until hospital discharge (1 week on average), up to 3 months

Study contacts

Contact information is provided by the study sponsor or research team.

Liesbeth Desender, MD, PhD

CONTACT

[email protected]

3293326148

Sponsors and collaborators

Lead sponsor

University Hospital, Ghent

Other

Collaborators

  • AZ Sint-Lucas Brugge

Registry information

Official study title

Reasons for Prolonged Hospital Stay After Thoracoscopic Anatomical Lung Resections

Acronym: PROTRACT

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Oct 15, 2024
Registry last updated
Jan 15, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.